This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
Bear of the Day: Delta Airlines (DAL)
by Madeleine Johnson
It's still tough to be an airline right now, but is this carrier on the road to recovery?
airlines coronavirus
What The Markets Are Pricing In & China's Winning Election Stock
by Daniel Laboe
There is one Chinese stock that you do not want to miss out on in this post election elation
coronavirus earnings emerging-markets finance tech-stocks
3 Stock Picks That Play on COVID Retail Therapy
by John Blank
Being Shut-In Delivers Offline Customers Too.
coronavirus retail
Update on the COVID Vaccine Race
by John Blank
A 2021 Macro Recovery is About This, Alone.
coronavirus
3 Stock Picks That Play on COVID Retail Therapy
by John Blank
Being Shut-In Delivers Offline Customers Too.
coronavirus retail
Big Tech Earnings, COVID Resurgence, and a Contentious Election: Which Will Be The Next Equity Market Driver?
by Daniel Laboe
Today we have some of the biggest and baddest tech giants reporting earnings after the bell, but will it be market moving?
coronavirus tech-stocks
Bull of the Day: Quidel (QDEL)
by Kevin Cook
Rapid COVID-19 tests that also screen influenza A+B have vaulted sales and profit growth 200-400%
coronavirus medical
Best COVID Drug Stocks to Buy on Trump Recovery
by David Bartosiak
Two of the best COVID drug stocks to buy became evident following President Trump's speedy recovery.
coronavirus pharmaceuticals
Coke Vs. Pepsi: Has COVID Changed The Odds?
by Daniel Laboe
A valuation divergence that had been wedged between this duopoly is now beginning to reverse
consumer-staples coronavirus large-cap
Why Regeneron Pharmaceuticals Jumped on Monday
by Madeleine Johnson
Shares of Regeneron Pharmaceuticals (REGN) surged higher on Monday as speculation grew that the FDA will authorize its coronavirus treatment for emergency use.
coronavirus pharmaceuticals